Los Alamos National Laboratory's Harshini Mukundan to Present at Biodetection Technologies 2014

BOSTON - Feb. 13, 2014 - PRLog -- 22nd International Conference
Biodetection Technologies
Technological Advances in Detection & Identification of Biological Threats
June 10-11, 2014 | Baltimore, MD

BIODETECTION TECHNOLOGIES 2014 - the 22nd conference in our Detection Technologies conference series - is an internationally recognized meeting for experts in detection & identification of biological threats and point-of-care analytical methods. This conference will review feedback from the end-users on biodefense and biomedical technologies and explore the cutting-edge in R&D and commercialization efforts in the field, including:

•    Rapid biosensing, biodetection and analysis
•    Simultaneous detection of multiple threats and pathogens
•    Discovery and analysis of biosignatures for the detection of host response
•    Point-of-care/clinical applications for pathogen/virus/threat detection and identification
•    Point-of-care assays for resource limited, lab and clinical settings; mobile labs
•    Advances in microarray and sequencing technologies
•    Field-deployable devices: portability/compatibility/reliability/scalability
•    Non-PCR vs. PCR based detection techniques
•    Issues of sensitivity/testing/evaluation/validation
•    Animal and plant pathogens
•    Bioelectronics
•    DNA chips, nucleic acid sensors and aptasensors
•    Enzyme-based biosensors
•    Immunosensors
•    Lab-on-a-chip
•    Microfluidics and immobilisation technology
•    Natural & synthetic receptors (including MIPs)
•    Organism- and whole cell-based biosensors
•    Proteomics, single-cell analysis and cancer-cell detection
•    Signal transduction technology (including magneto, piezo, optical and direct electrochemical techniques)

Featured Presentation:

Addressing Complex Clinical Problems with Novel Diagnostic Strategies
Harshini Mukundan, PhD, Research Scientist, Los Alamos National Laboratory
Dr. Mukundan will discuss advanced and integrated biodiagnostic strategies at LANL, spanning from rapid biomarker detection to advanced sequencing based analysis, to understand the circulation, emergence and occurrence of drug resistance in a pediatric population in rural Kenya. In addition, she will also talk about novel detection strategies used for the detection of bacterimia, including active tuberculosis, for the first time in this population.

CONFERENCE-AT-A-GLANCE

GENE AMPLIFICATION FOR BIOLOGICAL TARGET IDENTIFICATION

Increased Discrimination of Pathogens and Blood Donor Sample Multiplex Testing with an OpenArray Platform
Robert Duncan, PhD, Staff Scientist, FDA Center for Biologics Evaluation and Research, U.S. Food and Drug Administration

Treatment Guiding Detection of Burkholderia
R. Paul Schaudies, PhD, CEO, GenArraytion, Inc.

Conductive DNA Real-Time Simultaneous Detection of Multiple Targets
Fred Albert, PhD, President, Bridger Technologies, Inc.

A Fully Autonomous Biodetection System for Environmental Surveillance
Mark Burton, Northrop Grumman Corporation

Addressing Complex Clinical Problems with Novel Diagnostic Strategies
Harshini Mukundan, PhD, Research Scientist, Los Alamos National Laboratory

Enabling Point of Care Test Development for the STD Market
Joany Jackman, PhD, Investigator, Center for Point of Care Tests for STD, Johns Hopkins University School of Medicine

NOVEL DETECTION STRATEGIES FOR BIOLOGICAL TARGETS

Direct Multiplexed Virus Detection
John H. Connor, PhD, Professor, Dept of Microbiology, Boston University School of Medicine

Optimization of a Lateral Flow Immunoassay (LFI) for the Rapid Diagnosis of Melioidosis
David AuCoin, PhD, Research Assistant Professor, Dept Microbiology and Immunology, University of Nevada School of Medicine

Towards PCR-Free, Visual DNA Detection
Mahesh Uttamchandani, PhD, Assistant Professor, DSO National Laboratories, National University of Singapore, Singapore

Magneto-Hydrodynamic Focusing for Point of Care Applications
Christian Reis, Group Lead - Biotechnology Processes, Fraunhofer IPA, Germany

Bioaerosol Standoff Detection Using Lidar Technology Allowing Cloud Mapping and Spectrometric LIF Classification
Sylvie Buteau, PhD, Scientist, Defence Research and Development Canada, Canada

iTIRF - Cell Phone Based Biosensor for Molecular Diagnostics
Alexander N. Asanov, PhD, President and CSO, TIRF Labs, Inc.

Genomic-Based Approach for Tracking and Discriminating Pathogens
Willy Valdivia-Granda, PhD, CEO, Orion Integrated Biosciences Inc.

CHEMICAL AND TOXIN DETECTION

Novel Cell-Based Assay for Testing Active Ricin in Environmental Samples
Baolin Zhang, PhD, Senior Investigator, Division of Therapeutic Proteins, Office of Biotechnology Products, Food and Drug Administration

Automatic Online Real-Time Detection of Microcystin-LR Based on Optical Biosensing System
Han-Chang Shi, PhD, Professor, School of Environment, Tsinghua University, PR China

Microcantilever Enabled Biodetection
Rick Venedam, PhD, Senior Scientist, National Security Technologies, LLC

The Photonic Nose: A Versatile and Simple Sensing Tool
Leonardo Bonifacio, PhD, Research Scientist, Opalux Inc., Canada

New MEMS-based Micro-Coriolis Density Measurement Technology
Mike Touzin, Endress+Hauser Flowtec, Switzerland

Mid-Infrared QC Lasers for Molecular Recognition
Mariano Troccoli, PhD, Director of Product Development, AdTech Optics, Inc.

Host-Response Based Biodetection by Immunosignatures
Stephen Albert Johnston, PhD, Co-Director, Center for Innovations in Medicine, Professor, School of Life Sciences, Biodesign Institute, Arizona State University

TOOLS FOR DETECTION - MICROFLUIDICS AND ENZYMES

Tool Box of Engineered Microfluidic Components Shortens Development Time and Reduce Risk
Leanna Levine, PhD, CEO, Aline, Inc.

SoundStream - A Microfluidic-Based Assay Platform for Rapid Portable Diagnostics
Arlene Doria, PhD, CEO, DEFINEQA Inc.

Application of a Recombinant Topoisomerase for the Specific Enrichment of Prokaryotic DNA
Natalia Sandetskaya, PhD, Fraunhofer Institute for Cell Therapy and Immunology IZI, Germany

A Novel Thermostable Viral DNA Polymerase Facilitates Point of Care Molecular Detection of DNA and RNA Targets
Hemanth Shenoi, PhD, Lucigen Corp.

MEDIA CONTACT:

Craig Wohlers
Knowledge Foundation, a division of CHI
250 First Avenue, Suite 300
Needham, MA  02135
Phone: (617) 232 7400 ext 205
Fax: (617) 232 9171
email: cwohlers@knowledgefoundation.com